Study on the Effect of Inulin in Infant Formula on Gut Health

Inclusion criteria

at screening:

• Healthy infants between 3-4 months (91-120 days after birth) of age at day 1 of the study, with healthy growth determined based on WHO standard
• Fully formula-fed in the 28 days prior to inclusion
• Expected investigational product intake of min 500ml per day
• Written informed consent from the parents

Exclusion criteria

at screening:

• Low birth weight (LBW) less than 2,000g.
• Disorders requiring a special diet (such as food intolerance or food allergy or complaints such as reflux, constipation and cramps for which special toddler formula is required)
• Use of systemic antibiotics or antimycotics medication in the 14 days prior to the study
• Significant congenital abnormality that will interfere with the study objectives in the opinion of the investigator.
• Investigator's uncertainty about the willingness or ability of the parents to comply with the protocol requirements.
• Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.

Exclusion criteria

for intervention period:

• Not consuming study product longer than 2 days consecutively
• Intake of study product is less than 500ml per day for 7 days